PT1077681E - Composicao farmaceutica contendo levotiroxina sodio - Google Patents
Composicao farmaceutica contendo levotiroxina sodioInfo
- Publication number
- PT1077681E PT1077681E PT99922182T PT99922182T PT1077681E PT 1077681 E PT1077681 E PT 1077681E PT 99922182 T PT99922182 T PT 99922182T PT 99922182 T PT99922182 T PT 99922182T PT 1077681 E PT1077681 E PT 1077681E
- Authority
- PT
- Portugal
- Prior art keywords
- levotiroxin
- sodium
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229910052708 sodium Inorganic materials 0.000 title 1
- 239000011734 sodium Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19821625A DE19821625C1 (de) | 1998-05-15 | 1998-05-15 | Pharmazeutische Zubereitung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1077681E true PT1077681E (pt) | 2003-02-28 |
Family
ID=7867752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99922182T PT1077681E (pt) | 1998-05-15 | 1999-05-05 | Composicao farmaceutica contendo levotiroxina sodio |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6646007B1 (pt) |
| EP (1) | EP1077681B1 (pt) |
| JP (1) | JP4709379B2 (pt) |
| CN (1) | CN1145479C (pt) |
| AR (1) | AR018607A1 (pt) |
| AT (1) | ATE225651T1 (pt) |
| AU (1) | AU742382B2 (pt) |
| BR (1) | BRPI9910445B8 (pt) |
| CA (1) | CA2333193A1 (pt) |
| CZ (1) | CZ300908B6 (pt) |
| DE (2) | DE19821625C1 (pt) |
| DK (1) | DK1077681T3 (pt) |
| ES (1) | ES2184452T3 (pt) |
| HU (1) | HU228958B1 (pt) |
| ID (1) | ID27281A (pt) |
| MY (1) | MY120570A (pt) |
| NO (1) | NO331655B1 (pt) |
| PL (1) | PL194088B1 (pt) |
| PT (1) | PT1077681E (pt) |
| RU (1) | RU2225711C2 (pt) |
| SK (1) | SK284155B6 (pt) |
| TW (1) | TW561058B (pt) |
| UA (1) | UA73474C2 (pt) |
| WO (1) | WO1999059551A1 (pt) |
| ZA (1) | ZA200007509B (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
| US20030224047A1 (en) * | 2001-02-15 | 2003-12-04 | Franz G. Andrew | Levothyroxine compositions and methods |
| ITMI20011401A1 (it) * | 2001-07-02 | 2003-01-02 | Altergon Sa | Formulazioni farmaceutiche per ormoni tiroidei |
| US20030099699A1 (en) * | 2001-11-13 | 2003-05-29 | Hanshew Dwight D. | Storage stable thyroxine active drug formulations and methods for their production |
| US20040152783A1 (en) * | 2002-11-05 | 2004-08-05 | Olon Lawrence Peter | Controlled absorption of admixed thyroid hormone formulations |
| ITMI20022394A1 (it) | 2002-11-13 | 2004-05-14 | Bracco Spa | Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche. |
| ITMI20110713A1 (it) | 2011-04-29 | 2012-10-30 | Bracco Imaging Spa | Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina |
| GB0316206D0 (en) * | 2003-07-10 | 2003-08-13 | Glaxo Group Ltd | Pharmaceutical formulation |
| ATE390919T1 (de) | 2004-11-18 | 2008-04-15 | Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa | Trockenpulver mit levothyroxin-natrium mit verabreichung über einen inhalator |
| GB0525461D0 (en) * | 2005-12-15 | 2006-01-25 | Archimedes Dev Ltd | Pharmaceutical compositions |
| ITMI20062254A1 (it) * | 2006-11-24 | 2008-05-25 | Acraf | Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca |
| EP2885005B1 (en) * | 2012-08-20 | 2017-09-27 | Merck Patent GmbH | Solid pharmaceutical preparation containing levothyroxine |
| EP2932963A1 (en) | 2014-04-16 | 2015-10-21 | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. | Stable pharmaceutical dosage forms comprising Levothyroxine sodium |
| US9682045B2 (en) | 2014-11-21 | 2017-06-20 | Cadila Healthcare Limited | Stable pharmaceutical compositions of thyroid hormone drug |
| US20200046664A1 (en) | 2016-10-10 | 2020-02-13 | Ftf Pharma Private Limited | Method for preparation of liquid oral composition of l-thyroxin |
| CN109010295A (zh) * | 2018-08-29 | 2018-12-18 | 北京兴源联合医药科技有限公司 | 一种左甲状腺素钠冻干口腔崩解片 |
| CN115737576B (zh) * | 2022-11-14 | 2024-05-07 | 山东创新药物研发有限公司 | 一种左甲状腺素钠片剂及其制备方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR6191M (pt) | 1966-02-18 | 1968-07-22 | ||
| US3808332A (en) * | 1969-01-27 | 1974-04-30 | Armour Pharma | Pharmaceutical compositions containing the reaction product of a tertiary phosphine with thyroxine |
| US3621098A (en) | 1969-03-17 | 1971-11-16 | Geigy Chem Corp | HYPOTENSIVE METHODS AND COMPOSITIONS UTILIZING HEXAHYDROBENZO{8 b{9 {0 QUINOLIZINES |
| US3621096A (en) * | 1969-04-03 | 1971-11-16 | Univ North Carolina | Antidepressant method and composition for same comprising a tricyclic antidepressant and a thyroid hormone |
| DE2126533A1 (de) * | 1971-05-28 | 1972-12-14 | Merck Patent Gmbh, 6100 Darmstadt | Verfahren zur Herstellung pharma zeutischer Zubereitungen |
| HUT67319A (en) * | 1991-08-30 | 1995-03-28 | Life Medical Sciences Inc | Compositions for treating wounds |
| US5225204A (en) | 1991-11-05 | 1993-07-06 | Chen Jivn Ren | Stable dosage of levothyroxine sodium and process of production |
| SK279684B6 (sk) * | 1993-06-14 | 1999-02-11 | Janssen Pharmaceutica N.V. | Tableta a spôsob jej výroby |
| GB9325644D0 (en) * | 1993-12-15 | 1994-02-16 | Smithkline Beecham Plc | Novel formulation |
| CA2134611C (en) * | 1994-10-28 | 2002-12-24 | Richard John Yarwood | Process for preparing solid pharmaceutical dosage forms |
| SE9500897D0 (sv) * | 1995-03-14 | 1995-03-14 | Astra Ab | The pharmacological use of certain cystine derivatives |
| CN1126589A (zh) * | 1995-06-09 | 1996-07-17 | 中国科学院成都有机化学研究所 | 一种激素缓释微囊注射剂及其制备方法 |
| DE19541128C2 (de) * | 1995-10-27 | 1997-11-27 | Henning Berlin Gmbh & Co | Stabilisierte schilddrüsenhormonhaltige Arzneimittel |
| CA2235707A1 (en) * | 1995-11-14 | 1997-05-22 | Knoll Pharmaceutical Company | Stabilized thyroid hormone preparations and methods of making same |
| HUT75956A (en) * | 1995-11-29 | 1997-05-28 | Cyclolab | Pharmaceutical composition containing thyroxine |
| US20010039335A1 (en) * | 1997-04-10 | 2001-11-08 | Kenneth Jacobs | Secreted proteins and polynucleotides encoding them |
| FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
| DE19830246A1 (de) * | 1998-07-07 | 2000-01-13 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
-
1998
- 1998-05-15 DE DE19821625A patent/DE19821625C1/de not_active Expired - Lifetime
-
1999
- 1999-05-05 BR BRPI9910445A patent/BRPI9910445B8/pt not_active IP Right Cessation
- 1999-05-05 RU RU2000131588/15A patent/RU2225711C2/ru active
- 1999-05-05 CZ CZ20004201A patent/CZ300908B6/cs not_active IP Right Cessation
- 1999-05-05 AT AT99922182T patent/ATE225651T1/de active
- 1999-05-05 WO PCT/EP1999/003087 patent/WO1999059551A1/de active IP Right Grant
- 1999-05-05 PT PT99922182T patent/PT1077681E/pt unknown
- 1999-05-05 JP JP2000549216A patent/JP4709379B2/ja not_active Expired - Lifetime
- 1999-05-05 EP EP99922182A patent/EP1077681B1/de not_active Expired - Lifetime
- 1999-05-05 PL PL99346395A patent/PL194088B1/pl unknown
- 1999-05-05 AU AU39321/99A patent/AU742382B2/en not_active Expired
- 1999-05-05 UA UA2000127207A patent/UA73474C2/uk unknown
- 1999-05-05 ID IDW20002460A patent/ID27281A/id unknown
- 1999-05-05 CN CNB998061751A patent/CN1145479C/zh not_active Expired - Lifetime
- 1999-05-05 US US09/700,421 patent/US6646007B1/en not_active Expired - Lifetime
- 1999-05-05 SK SK1689-2000A patent/SK284155B6/sk not_active IP Right Cessation
- 1999-05-05 CA CA002333193A patent/CA2333193A1/en not_active Withdrawn
- 1999-05-05 DE DE59903028T patent/DE59903028D1/de not_active Expired - Lifetime
- 1999-05-05 HU HU0102125A patent/HU228958B1/hu unknown
- 1999-05-05 DK DK99922182T patent/DK1077681T3/da active
- 1999-05-05 ES ES99922182T patent/ES2184452T3/es not_active Expired - Lifetime
- 1999-05-12 MY MYPI99001885A patent/MY120570A/en unknown
- 1999-05-14 AR ARP990102301A patent/AR018607A1/es active IP Right Grant
- 1999-05-14 TW TW088107870A patent/TW561058B/zh not_active IP Right Cessation
-
2000
- 2000-11-14 NO NO20005758A patent/NO331655B1/no not_active IP Right Cessation
- 2000-12-14 ZA ZA200007509A patent/ZA200007509B/en unknown
-
2003
- 2003-09-15 US US10/661,588 patent/US8008349B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID27415A (id) | Komposisi farmaseutik | |
| NO20005913L (no) | Legemiddelsammensetning | |
| IS5046A (is) | Lyfjasamsetningar | |
| NO20015175L (no) | Farmasöytisk sammensetning | |
| ID29262A (id) | Komposisi farmasi | |
| ID26186A (id) | Komposisi sampo | |
| ID28694A (id) | Komposisi sampo | |
| DE69924999D1 (de) | Lipasehemmer enthaltende pharmazeutische zusammensetzungen | |
| DK0945132T3 (da) | Ibuprofen-præparat | |
| ID29430A (id) | Komposisi herbisida | |
| DE69942892D1 (de) | Gaserzeugende zusammensetzung | |
| PT1077681E (pt) | Composicao farmaceutica contendo levotiroxina sodio | |
| DE69928862D1 (de) | Zusammensetzung | |
| ID27201A (id) | Komposisi farmasi | |
| NO20010089D0 (no) | Farmasöytisk levotyroksinpreparat | |
| ID29294A (id) | Komposisi farmasi | |
| ID30032A (id) | Formulasi farmasi | |
| PT1227817E (pt) | Composicao farmaceutica aquosa contendo ciclesonida | |
| ID25857A (id) | Komposisi farmasi | |
| FI4488U1 (fi) | Farmaseuttinen koostumus | |
| EE200100281A (et) | Analgeetiline ravimkoostis | |
| ID26215A (id) | Komposisi farmasi | |
| ID26295A (id) | Komposisi keras-ultraviolet | |
| ID28359A (id) | Komposisi | |
| DE69939964D1 (de) | Gelförmige Zusammensetzung |